Psychiatric Bulletin (2003) 27: 14-16. doi: 10.1192/pb.27.1.14
© 2003 The Royal College of Psychiatrists
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Bains, J. J. S.
Right arrow Articles by Nielssen, O. B.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Bains, J. J. S.
Right arrow Articles by Nielssen, O. B.
Psychiatric Bulletin (2003) 27: 14-16
© 2003 The Royal College of Psychiatrists

Combining depot antipsychotic medications with novel antipsychotics in forensic patients: a practice in search of a principle

Jatinder J. S. Bains, Consultant Psychiatrist (Manly Hospital) and Lecturer in Psychiatry (Sydney University)

East Wing, Manly Hospital, Darley Rd, NSW 2066, Australia

Olav B. Nielssen, Consultant Psychiatrist

Corrections Health Service, Matraville, Australia

Declaration of interest

Both J. B. and O. N. were employees of Long Bay Prison Hospital (Corrections Health Service) at the time the research was conducted. O. N. has received payment for lectures sponsored by GlaxoSmithKline and Janssen Cilag.

OBJECTIVE

We observed a pattern of combining depot antipsychotic medication with the newer ‘atypical’ antipsychotics in forensic patients. We aimed to determine the prevalence and rationale for such ‘combination therapy’.

METHOD

The medical records of forensic patients in 3 forensic hospitals in New South Wales, Australia, were reviewed and the responsible psychiatrists asked to explain the rationale for treatment of those patients on combination therapy.

RESULTS

Twenty-two per cent of the forensic patient population were receiving combination therapy. The reasons given for combination therapy were the presence of treatment-resistant illness, to ensure adherence to at least part of the treatment and to assist transfer to lower security units.

CONCLUSIONS

Such a high prevalence of a practice that is discouraged and without theoretical justification is a cause for concern. It appeared to reflect the practical difficulties of managing forensic patients.




This article has been cited by other articles:


Home page
 Br. J. PsychiatryHome page
T. R. E. Barnes, A. Shingleton-Smith, and C. Paton
Antipsychotic long-acting injections: prescribing practice in the UK
The British Journal of Psychiatry, November 1, 2009; 195(52): S37 - S42.
[Abstract] [Full Text] [PDF]

Home page
 Adv. Psychiatr. Treat.Home page
M. X. Patel and A. S. David
Why aren't depot antipsychotics prescribed more often and what can be done about it?
Adv. Psychiatr. Treat., May 1, 2005; 11(3): 203 - 211.
[Abstract] [Full Text] [PDF]

Home page
 Psychiatr. Bull.Home page
W. Engelhardt
Combination therapy
Psychiatr. Bull., April 1, 2003; 27(4): 157 - 157.
[Full Text] [PDF]